Anticipating the future, the incorporation of AMPs into antimicrobial therapy presents a promising avenue to not only overcome present treatment barriers for multidrug-resistant infections but also to help shape a future in which the prevalence of antibiotic resistance is considerably reduced, protecting global public health outcomes. The gene discussed is ADSL; the disease is infection.